Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jul;45(7):675-684.
doi: 10.15537/smj.2024.45.7.20240156.

Biomarker for cardiorenal syndrome risk in patients with liver cirrhosis and type 2 diabetes in Saudi Arabia

Walaa Mohammedsaeed  1 , Zain J Alghamdi  1
Affiliations

Biomarker for cardiorenal syndrome risk in patients with liver cirrhosis and type 2 diabetes in Saudi Arabia

Walaa Mohammedsaeed et al. Saudi Med J. 2024 Jul.

Abstract

Objectives: To evaluate the correlation between different attributes, levels of biomarkers, and the probability of developing cardiorenal syndrome (CRS) in patients who have been diagnosed with type 2 diabetes mellitus (T2DM) and liver cirrhosis (LC). The hypothesis suggests that liver illness may be linked to renal impairment, cardiac dysfunction, and the development of cardiorenal syndrome METHODS: The current study retrospectively assessed the medical records of patients who had LC and T2DM diagnoses and were hospitalized at Al Madina Al Munwara hospitals in 2022 and 2023.

Results: This research investigated T2DM patients with physician-confirmed to have LC. Poor glycemic control is indicated by high blood glucose and glycated hemoglobin (HbA1c) readings in research participants. High blood pressure, atherogenic plasma indicator (AIP), and obesity plagued most of these individuals. High creatinine, moderate estimated Glomerular Filtration Rate (eGFR) decline, and a modest urinary albumin-to-creatinine (UACR) rise were the most prevalent variables in LC and T2DM patients. Cardiorenal syndrome risk factors, including elevated blood pressure, triglyceride levels, body mass index (BMI), and high-sensitivity C-reactive protein (hs-CRP) concentrations, were identified through logistic regression. It has been demonstrated that the prevalence of these risk factors increases with age; women may be at a greater risk for developing CRS. Specific biomarker evaluations classified 108 (22.6%) LC and T2DM patients at high risk for chronic kidney disease (CKD), 100 (20%) at risk for cardiovascular disease (CVD), and 91 (18.2%) at risk for CRS.

Conclusion: The current assessment included 500 patients with T2DM and LC. The risk factors for CRS identified in this study included elevated cholesterol and triglyceride levels, high BMI, and elevated blood pressure, with age being a significant factor, particularly in female patients. Early identification of these characteristics in patients with LC and T2DM could aid in mitigating the progression of chronic illnesses and their associated complications.

Keywords: Saudi; biomarkers; cardiorenal; liver cirrhosis; syndrome.

PubMed Disclaimer

Figures

Figure 1
Figure 1
- The study protocol’s graphic is presented.
See this image and copyright information in PMC

References

    1. Nakahara T, Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD), Hyogo H, Yoneda M, Sumida Y, Eguchi Y, et al. . Type 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patients. J Gastroenterol 2013: 49; 1477–1484. - PubMed
    1. Hamaguchi M, Kojima T, Takeda N, Nakagawa T, Taniguchi H, Fujii K, et al. . The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med 2005: 143; 722–728. - PubMed
    1. Lee DS, Gona P, Vasan RS, Larson MG, Benjamin EJ, Wang TJ, et al. , Relation of disease pathogenesis and risk factors to HF with preserved or reduced ejection fraction: Insights from the framingham heart study of the national heart, lung, and blood institute. Circulation. 2009:119;3070–3077. - PMC - PubMed
    1. Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, et al. . Obesity and the risk of HF. N Engl J Med 2002: 347; 305–313. - PubMed
    1. Nichols GA, Gullion CM, Koro CE, Ephross SA, Brown JB. The incidence of congestive HF in type 2 diabetes: An update. Diabetes Care 2004: 27; 1879–1884. - PubMed

MeSH terms